🇺🇸 FDA
Patent

US 11345930

Codon optimized RPGRORF15 genes and uses thereof

granted A61KA61K48/0041A61K48/005

Quick answer

US patent 11345930 (Codon optimized RPGRORF15 genes and uses thereof) held by 4D MOLECULAR THERAPEUTICS INC. expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
4D MOLECULAR THERAPEUTICS INC.
Grant date
Tue May 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K48/0041, A61K48/005, A61K48/0058, A61K48/0066